1. Home
  2. OCUL

OCUL

Ocular Therapeutix Inc.

Logo Ocular Therapeutix Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Founded: 2006 Country:
United States
United States
Employees: N/A City: BEDFORD
Market Cap: 1.2B IPO Year: 2014
Target Price: $16.33 AVG Volume (30 days): 2.1M
Analyst Decision: Buy Number of Analysts: 6
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.02 EPS Growth: N/A
52 Week Low/High: $2.00 - $11.31 Next Earning Date: 05-06-2024
Revenue: $58,443,000 Revenue Growth: 13.49%
Revenue Growth (this year): 18.76% Revenue Growth (next year): 24.92%

Share on Social Networks: